PreveCeutical Medical Inc. (CSE: PREV)
Canada
· Delayed Price · Currency is CAD 0.0250
+0.0050 (25.00%)
Dec 19, 2024, 9:30 AM EST
PreveCeutical Medical Statistics
Total Valuation
PreveCeutical Medical has a market cap or net worth of CAD 13.54 million. The enterprise value is 17.84 million.
| Market Cap | 13.54M |
| Enterprise Value | 17.84M |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PreveCeutical Medical has 541.70 million shares outstanding. The number of shares has increased by 0.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 541.70M |
| Shares Change (YoY) | +0.43% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.91% |
| Owned by Institutions (%) | n/a |
| Float | 439.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -44.71 |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -10.77 |
| Interest Coverage | -2.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -179.34% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.94 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 59.92 |
| Average Volume (20 Days) | 78,837 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -952,833 |
| Pretax Income | -1.36M |
| Net Income | -1.36M |
| EBITDA | -942,822 |
| EBIT | -952,833 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 236 in cash and 4.30 million in debt, giving a net cash position of -4.30 million or -0.01 per share.
| Cash & Cash Equivalents | 236 |
| Total Debt | 4.30M |
| Net Cash | -4.30M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -6.28M |
| Book Value Per Share | -0.01 |
| Working Capital | -6.34M |
Cash Flow
In the last 12 months, operating cash flow was -397,963 and capital expenditures -1,077, giving a free cash flow of -399,040.
| Operating Cash Flow | -397,963 |
| Capital Expenditures | -1,077 |
| Free Cash Flow | -399,040 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PreveCeutical Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.43% |
| Shareholder Yield | -0.43% |
| Earnings Yield | -10.12% |
| FCF Yield | -2.95% |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |